Meet EU MDR and FDA requirements for medical device documentation translation. ISO 13485 certification opens the door to the highest-paying segment of the translation industry.
ISO 13485:2016, "Medical devices — Quality management systems — Requirements for regulatory purposes," is the internationally recognized quality management standard for the medical device industry. While it was originally designed for medical device manufacturers, its scope explicitly includes organizations that provide services affecting medical device quality — and that includes translation agencies that translate medical device documentation.
Medical device documentation translation is not ordinary translation work. When a patient reads an Instructions for Use (IFU) leaflet that has been translated into their language, their health and safety depend on the accuracy of that translation. When a surgeon follows a translated surgical guide, or a clinical investigator reads a translated study protocol, there is zero margin for error. This is why regulators worldwide have established stringent requirements for the quality management systems of organizations involved in medical device documentation.
ISO 13485 provides the framework for establishing and maintaining a quality management system (QMS) that demonstrates your organization's ability to consistently provide medical device translation services that meet customer and regulatory requirements. It is aligned with, but distinct from, ISO 9001, with specific modifications and additions relevant to the medical device sector.
Medical device documentation translation sits at the intersection of two highly regulated domains: medical device regulation and language service quality. Understanding the regulatory landscape is essential for any translation agency considering this market:
ISO 13485 certification positions your agency to handle the full spectrum of medical device documentation:
Medical device translation is one of the highest-paying segments of the translation industry. Rates for medical device IFU translation typically range from 30% to 100% higher than general translation rates, and specialized clinical documentation commands even higher premiums. This premium reflects the risk, expertise, and quality requirements involved.
The global medical device market is projected to exceed $600 billion by 2027, and every device sold in a foreign market needs translated documentation. With the EU MDR transition requiring manufacturers to update and retranslate documentation for thousands of legacy devices, the demand for qualified medical translation providers has never been higher.
The EU Medical Device Regulation, which replaced the Medical Devices Directive (MDD), has created a massive wave of documentation work. Manufacturers must update their technical documentation, clinical evaluations, and labeling to comply with the new regulation. Since the MDR applies to both new and legacy devices, the translation workload is enormous. Notified Bodies conducting conformity assessments are specifically checking that manufacturers use qualified, quality-assured translation providers.
For medical device manufacturers targeting the US market, the FDA expects documentation to be produced under controlled quality management systems. Having an ISO 13485-certified translation provider simplifies the manufacturer's own regulatory submissions and compliance documentation. The FDA's increasing focus on labeling accuracy, particularly after several high-profile recalls caused by translation errors, makes ISO 13485 certification an increasingly valuable differentiator.
A critical component of ISO 13485 that distinguishes it from other quality standards is its emphasis on risk management. In medical translation, risk management means systematically identifying, evaluating, and controlling translation-related risks that could affect patient safety. This includes:
ISO 13485 establishes comprehensive quality management requirements tailored to the medical device sector.
Establish and maintain a documented QMS covering all translation processes for medical device documentation. Includes quality manual, quality policy, quality objectives, and controlled procedures for every aspect of the translation workflow.
Implement risk management throughout the translation process in alignment with ISO 14971. Identify, evaluate, and control risks associated with medical translation, with particular attention to patient safety-critical content.
Maintain complete traceability for every translated document: source version control, translator assignment, review records, change history, and delivery confirmation. Essential for regulatory audits and post-market surveillance.
Implement rigorous document control procedures: version management, approval workflows, distribution control, and obsolete document management. Medical device documentation requires zero ambiguity about which version is current.
Validate translation processes and verify outputs. This includes competence verification of translators, validation of CAT tools used for medical content, and verification of translated document accuracy against source.
Implement Corrective and Preventive Action (CAPA) procedures for handling non-conformities. When translation errors are identified, conduct root cause analysis, implement corrections, and prevent recurrence through systemic improvements.
TranslationCert guides you through every step of medical device QMS certification.
Complete our specialized medical translation assessment that evaluates your processes against ISO 13485 requirements. Identifies gaps in quality management, risk management, traceability, and document control.
Receive a comprehensive medical device QMS documentation package: quality manual, SOPs for medical translation workflows, risk management procedures, CAPA forms, and traceability templates. Tailored specifically for LSPs.
Deploy the QMS across your organization. Establish document control, train staff on medical device quality requirements, implement risk-based translation workflows, and set up your CAPA system.
BALTUM auditors with medical device experience conduct a two-stage certification audit: Stage 1 reviews documentation readiness, Stage 2 verifies implementation effectiveness through process observation and record review.
Receive your ISO 13485 certificate with IAF MLA recognition, valid for three years with annual surveillance audits. Includes ongoing support for maintaining compliance as regulations evolve.
ISO 13485 certification positions your agency in the most lucrative segment of the translation industry.
Major medical device manufacturers (Medtronic, J&J, Boston Scientific, Siemens Healthineers) require ISO 13485 from translation vendors.
Medical device translation rates are 30-100% higher than general translation. ISO 13485 certification justifies and protects these premium rates.
Demonstrate to manufacturers and Notified Bodies that your translation processes meet the quality management requirements of the EU MDR.
ISO 13485 is recognized by the FDA. Certification strengthens the regulatory position of manufacturers who use your services.
Risk management processes ensure patient safety-critical content receives the highest level of quality assurance.
Audit-ready documentation trail for every medical translation project, essential for regulatory inspections and post-market surveillance.
Medical device clients prefer long-term relationships due to the cost of vendor qualification. Certification leads to multi-year retainer agreements.
Medical devices require ongoing documentation updates, IFU revisions, and label changes across their lifecycle, creating stable recurring revenue.
Everything you need to know about ISO 13485 certification for medical translation agencies.
No. ISO 13485 explicitly applies to any organization involved in the medical device lifecycle, including those that provide services affecting device quality. Translation agencies certify under a scope such as "design and development of medical device documentation translation services" or "provision of translation services for medical device labeling and documentation." You are certifying your quality management system for medical translation, not manufacturing devices.
ISO 13485 covers all documentation associated with medical devices: Instructions for Use (IFUs), product labeling, clinical evaluation reports, risk management files, technical documentation, patient information leaflets, surgical guides, training materials, regulatory submission documents, post-market surveillance reports, and any other documentation that forms part of the medical device's quality management system or regulatory file.
The EU MDR requires that all medical device documentation be available in the official languages of EU member states where devices are placed on the market. Manufacturers must demonstrate that their entire supply chain, including translation providers, operates under appropriate quality management. ISO 13485 certification provides Notified Bodies and regulators with evidence that your translation processes meet these quality requirements. Many manufacturers now require ISO 13485 from translation vendors as a condition of engagement.
The FDA recognizes ISO 13485 as evidence of quality management system compliance. While the FDA does not mandate that translation vendors hold ISO 13485, manufacturers submitting 510(k) or PMA applications benefit from demonstrating that their translation supply chain is quality-controlled. With the FDA's increasing focus on labeling accuracy and post-market surveillance, ISO 13485 certification from translation providers is becoming a competitive differentiator in the US market.
Translators do not need medical degrees, but they must demonstrate competence in medical translation. ISO 13485 requires that personnel affecting product quality have appropriate education, training, skills, and experience. For medical translators, this means demonstrated knowledge of medical terminology, understanding of regulatory document types (IFUs, labeling requirements), and familiarity with the medical device regulatory landscape. Competence records must be maintained for all translators working on medical projects.
With TranslationCert, expect 3-6 weeks depending on your current process maturity. Agencies that already have ISO 17100 or ISO 9001 will find significant overlap in quality management system requirements. The main additional investment is in establishing medical-specific procedures: risk management, CAPA, traceability, and document control aligned with medical device regulatory expectations.
Absolutely. Many leading medical translation agencies hold both certifications. ISO 17100 covers general translation service quality, while ISO 13485 adds the medical device-specific quality management layer. TranslationCert can help you build an integrated management system that satisfies both standards efficiently, avoiding duplication of effort and documentation.
CAPA stands for Corrective and Preventive Action. It is a systematic approach to identifying, investigating, and resolving quality issues. When a translation error or process non-conformity is identified, your CAPA system requires you to: document the issue, conduct root cause analysis, implement corrective actions to fix the immediate problem, implement preventive actions to prevent recurrence, and verify the effectiveness of actions taken. CAPA is one of the most scrutinized elements during ISO 13485 audits.